Literature DB >> 31383395

Long-Term Management of Neovascular Age-Related Macular Degeneration: To Suspend or Not to Suspend?

Rahul N Khurana1.   

Abstract

Mesh：

Substances：

Year:  2019        PMID： 31383395     DOI： 10.1016/j.oret.2019.04.013

Source DB:  PubMed          Journal:  Ophthalmol Retina        ISSN： 2468-6530


× No keyword cloud information.
  3 in total

1.  Effects of suspension of anti-vascular endothelial growth factor treatment for neovascular age-related macular degeneration in clinical setting.

Authors:  Hisashi Matsubara; Yoshitsugu Matsui; Ryohei Miyata; Atsushi Ichio; Shinichiro Chujo; Hiroko Enomoto; Masahiko Sugimoto; Mineo Kondo
Journal:  Graefes Arch Clin Exp Ophthalmol       Date:  2022-01-30       Impact factor: 3.535

Review 2.  Neovascular age-related macular degeneration: A review of findings from the real-world Fight Retinal Blindness! registry.

Authors:  Vuong Nguyen; Daniel Barthelmes; Mark C Gillies
Journal:  Clin Exp Ophthalmol       Date:  2021-06-21       Impact factor: 4.207

3.  Continued anti-VEGF treatment does not prevent recurrences in eyes with stable neovascular age-related macular degeneration using a treat-and-extend regimen: a retrospective case series.

Authors:  Peter G Traine; Richard A Garweg; Justus G Garweg; Juliana Wons; Christin Gerhardt; Isabel B Pfister
Journal:  Eye (Lond)       Date:  2021-05-03       Impact factor: 3.775
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.